PC
Vaxcyte
PCVX·NASDAQSan Carlos CAFounded 2018150 employees
Mid CapbiotechPublicInfectious Disease
Platform: Pneumococcal Vax
Market Cap
$8B
All Drugs
4
Clinical Trials
7
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (PCVX)
Loading PCVX stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Polatapinarof | PCV-1457 | Approved | 3 | AuroraA | MG | ||
| Mavuinavolisib | PCV-2619 | NDA/BLA | 1 | SHP2 | PompeCrohn's | ||
| PCV-2362 | PCV-2362 | Phase 1 | 2 | TIGIT | PSPMG | ||
| PCV-5987 | PCV-5987 | Phase 2/3 | 1 | JAK2 | RSV |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (8)